CRDF
Price
$0.93
Change
-$0.01 (-1.06%)
Updated
Oct 22 closing price
Capitalization
72.19M
13 days until earnings call
Intraday BUY SELL Signals
DBVT
Price
$9.68
Change
+$0.06 (+0.62%)
Updated
Oct 22 closing price
Capitalization
608.37M
5 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRDF vs DBVT

CRDF vs DBVT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRDF vs. DBVT commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDF is a Hold and DBVT is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CRDF with price predictions
Oct 22, 2026

CRDF in downward trend: price dove below 50-day moving average on October 08, 2026

CRDF moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend. In 38 of 43 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRDF as a result. In 79 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

The Moving Average Convergence Divergence Histogram (MACD) for CRDF turned negative on September 25, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 34 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.

The 10-day moving average for CRDF crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRDF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for CRDF entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CRDF's RSI Indicator exited the oversold zone, 24 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRDF advanced for three days, in 208 of 242 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

CRDF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. CRDF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.721) is normal, around the industry mean (2.973). P/E Ratio (-1.547) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (178.571) is also within normal values, averaging (438.009).

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRDF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for DBVT with price predictions
Oct 22, 2026

DBVT in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 02, 2026

DBVT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 37 of 42 cases where DBVT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where DBVT's RSI Indicator exited the oversold zone, 24 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 65%.

The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on DBVT as a result. In 67 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.

The Moving Average Convergence Divergence (MACD) for DBVT just turned positive on October 20, 2026. Looking at past instances where DBVT's MACD turned positive, the stock continued to rise in 40 of 50 cases over the following month. The odds of a continued upward trend are 80%.

Following a +2.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where DBVT advanced for three days, in 161 of 202 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DBVT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for DBVT entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.790) is normal, around the industry mean (2.973). P/E Ratio (-2.766) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (75.432) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. DBVT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DBVT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
CRDF vs DBVT: Fundamental Ratings
CRDF
DBVT
OUTLOOK RATING
1..100
5556
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
6585
P/E GROWTH RATING
1..100
5515
SEASONALITY SCORE
1..100
4913

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DBVT's Valuation (65) in the Biotechnology industry is in the same range as CRDF (69) in the null industry. This means that DBVT’s stock grew similarly to CRDF’s over the last 12 months.

DBVT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CRDF (100) in the null industry. This means that DBVT’s stock grew similarly to CRDF’s over the last 12 months.

CRDF's SMR Rating (98) in the null industry is in the same range as DBVT (99) in the Biotechnology industry. This means that CRDF’s stock grew similarly to DBVT’s over the last 12 months.

CRDF's Price Growth Rating (65) in the null industry is in the same range as DBVT (85) in the Biotechnology industry. This means that CRDF’s stock grew similarly to DBVT’s over the last 12 months.

DBVT's P/E Growth Rating (15) in the Biotechnology industry is somewhat better than the same rating for CRDF (55) in the null industry. This means that DBVT’s stock grew somewhat faster than CRDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRDFDBVT
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
65%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (CRDF: $0.93 vs. DBVT: $9.68)
Brand notoriety: CRDF and DBVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRDF: 30% vs. DBVT: 27%
Market capitalization -- CRDF: $72.19M vs. DBVT: $608.37M
CRDF [@Biotechnology] is valued at $72.19M. DBVT’s [@Biotechnology] market capitalization is $608.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRDF’s FA Score shows that 0 FA rating(s) are green while DBVT’s FA Score has 1 green FA rating(s).

  • CRDF’s FA Score: 0 green, 5 red.
  • DBVT’s FA Score: 1 green, 4 red.
According to our system of comparison, DBVT is a better buy in the long-term than CRDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRDF’s TA Score shows that 4 TA indicator(s) are bullish while DBVT’s TA Score has 5 bullish TA indicator(s).

  • CRDF’s TA Score: 4 bullish, 6 bearish.
  • DBVT’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, DBVT is a better buy in the short-term than CRDF.

Price Growth

CRDF (@Biotechnology) experienced а -4.43% price change this week, while DBVT (@Biotechnology) price change was +6.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.

Reported Earning Dates

CRDF is expected to report earnings on Nov 05, 2026.

DBVT is expected to report earnings on Oct 27, 2026.

Industries' Descriptions

@Biotechnology (-1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CRDF
Daily Signal:
Gain/Loss:
DBVT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

DBVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, DBVT has been loosely correlated with KYMR. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if DBVT jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBVT
1D Price
Change %
DBVT100%
+0.62%
KYMR - DBVT
35%
Loosely correlated
-1.58%
GPCR - DBVT
35%
Loosely correlated
-0.36%
CRDF - DBVT
32%
Poorly correlated
-1.17%
CGEN - DBVT
31%
Poorly correlated
-7.55%
OCUL - DBVT
31%
Poorly correlated
+2.01%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EYEG33.880.28
+0.83%
AB Corporate Bond ETF (EYEG)
AJUL30.37N/A
N/A
Innovator 2 Yr to July 2028 (AJUL)
CMAY26.00N/A
N/A
Corgi U.S. Equities 15% Structured Buffer ETF (CMAY)
QQQE117.63-1.74
-1.46%
Direxion NASDAQ-100 Equal Weighted Index ETF (QQQE)
HAP73.46-1.10
-1.48%
VanEck Natural Resources ETF (HAP)